Biotech peptides research is reshaping how medicines are built—shifting from broad-spectrum medicines toward remarkably precise molecules that may be tuned for potency, selectivity, and affected individual compatibility. In my watch, the most enjoyable shift will not be just that peptides are “better,” but that all the discovery pipeline—sy